Start trading now on Poste Italiane

Olink acquried by Thermo Fisher at nearly 75% premium following earlier deal rumors

|

© Olink acquried by Thermo Fisher at nearly 75% premium following earlier deal rumors

Shares of Olink Holding AB (NASDAQ:) surged 66% higher Tuesday after the company agreed to be acquired by Thermo Fisher Scientific Inc. (NYSE:) for $26 per ADS, or approximately $3.1 billion.

Today’s news follows an exclusive StreetInsider.com report in August that Olink hired investment bank JP Morgan to .

The takeover comes at an approximately 74% premium to Olink’s closing price on Monday.

Olink seeks to advance proteomics across various diseases and offers a broad portfolio of flexible protein biomarker solutions and library of high quality, thoroughly validated assays that cover ~3000 proteins.

Thermo Fisher expects Olink to deliver $200 million in revenue in 2024 and grow mid-teens organically. In the first, Thermo Fisher expects the transaction to be dilutive to EPS by $0.17, but excluding financing costs and non-cash deal-related equity compensation costs, the transaction is expected to be accretive by $0.10.

J.P. Morgan was the lead financial advisor for Olink. In addition, Goldman Sachs Bank Europe SE and Sweden Bankfilial served as financial advisors and Baker & McKenzie is serving as legal counsel for Olink. Cravath Swaine & Moore LLP and Advokatfirman Vinge KB were legal counsel for Thermo Fisher.

Previous Post
Goldman profit tops estimates as dealmaking cushions hit from GreenSky, real estate
Next Post
Lockheed beats estimates on sustained weapons demand amid geopolitical tensions

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Invest on crypto with Gianluca Vacchi project and start making money now
Win money trading on Amazon
INVEST NOW
keyboard_arrow_up